Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

Clinical trial NCT03506139 · WITHDRAWN

Trial details

NCT number: NCT03506139
Sponsor: John M. Buatti
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma Multiforme

Start date: 2019-05-15
Primary completion: 2024-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.